Skip to main content

Specialties
Resources for Physicians
Resources for Your Patients

Search Videos and More

search

Channel Categories

Cancer (71)
Cardiology, Heart & Vascular Surgery (1)
Gastroenterology (2)
Obstetrics & Gynecology (4)
Ophthalmology (1)
Orthopaedics (1)
Otolaryngology (1)
Urology (1)

Types

News (71)

Conditions

[A06.4] Amebic liver abscess (1)
[C01] Tongue Cancer (1)
[C14] Throat Cancer (1)
[C22.0] Liver cell carcinoma (1)
[C22.3] Angiosarcoma of liver (1)
[C22.8] Liver Cancer (3)
[C25.3] Pancreatic Cancer (5)
[C34.90] Lung Cancer (2)
[C43.0] Malignant melanoma of lip (1)
[C43.1] Malignant melanoma of eyelid, including canthus (1)
[C44.90] Skin Cancer (3)
[C50.1] Malignant neoplasm of central portion of breast (1)
[C50.919] Triple-negative Breast Cancer (5)
[C50.91] Malignant neoplasm of breast of unspecified site, female (1)
[C50.9] Malignant neoplasm of breast of unspecified site (1)
[C50] Breast Cancer (6)
[C53.0] Malignant neoplasm of endocervix (1)
[C53.1] Malignant neoplasm of exocervix (1)
[C53.8] Malignant neoplasm of overlapping sites of cervix uteri (1)
[C53.9] Malignant neoplasm of cervix uteri, unspecified (1)
[C53] Malignant neoplasm of cervix uteri (1)
[C61] Prostate Cancer (1)
[C64] Kidney Cancer (1)
[C71.9] Glioblastoma (2)
[C76.0] Head and Neck Cancer (2)
[C78.6] Secondary malignant neoplasm of retroperitoneum and peritoneum (1)
[C79.89] Secondary malignant neoplasm of other specified sites (1)
[C80.0] Disseminated malignant neoplasm, unspecified (1)
[C80.1] Malignant (primary) neoplasm, unspecified (2)
[C80] Malignant neoplasm without specification of site (1)
[D72.0] Genetic anomalies of leukocytes (1)
[G62.82] Radiation-induced polyneuropathy (1)
[H05.32] Deformity of orbit due to bone disease (1)
[I42.7] Cardiomyopathy due to drug and external agent (1)
[I42] Cardiomyopathy (1)
[K86.9] Disease of pancreas, unspecified (1)
[M89.9] Metabollic Bone Disease (1)
[N39.0] Urinary Tract Infection (1)
[Z68.5] Body mass index (BMI) pediatric (1)

Procedures

[0003U] Measurement of proteins associated with ovarian cancer in serum (3)
[0005U] Test for detecting genes associated with prostate cancer in urine (3)
[0014U] DNA test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow (1)
[0022U] DNA and RNA gene analysis for non-small cell lung cancer (1)
[0030U] Gene analysis of targeted sequences for warfarin drug response (1)
[0036U] Exome gene analysis for somatic mutation in tumor tissue (1)
[0067U] Protein expression profiling of 4 biomarkers of breast cancer in precancerous breast tissue (1)
[00702] Anesthesia for liver biopsy (accessed through the skin) (1)
[00732] Anesthesia for diagnostic examination of gallbladder and pancreatic, liver, and bile ducts using an endoscope (2)
[0102U] Gene sequence analysis panel of 17 genes associated with hereditary breast cancer and related disorders (1)
[0131U] Targeted mRNA sequence analysis of 13 genes associated with hereditary breast cancer and related disorders (1)
[0166U] Liver disease test panel in serum specimen (1)
[0172U] DNA gene analysis (BRCA1, DNA repair associated and BRCA2, DNA repair associated) for detection of mutations associated with breast cancer (1)
[01922] Anesthesia for X-ray or radiation therapy (1)
[19294] Preparation of tumor cavity and placement of radiation therapy applicator into breast for radiation therapy concurrent with partial breast removal (2)
[28540] Closed treatment of ankle joint bone dislocation (1)
[28545] Closed treatment of ankle joint bone dislocation under anesthesia (1)
[48150] Whipple Procedure (1)
[49327] Examination of abdomen with insertion of devices for radiation therapy using endoscope (1)
[58210] Abdominal removal of uterus, cervix, and lymph nodes on both sides of pelvis and aortic lymph node biopsy (1)
[77261] Management of radiation therapy, simple (12)
[77262] Management of radiation therapy, intermediate (2)
[77263] Management of radiation therapy, complex (1)
[77427] Radiation Therapy (1)
[77799] Administration of radiation therapy (10)
[78815] Nuclear medicine study with CT imaging skull base to mid-thigh (1)
[81479] Molecular pathology procedure (1)
[87086] Bacterial colony count, urine (1)
[87088] Bacterial urine culture (1)
[87184] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) (1)
[87186] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (1)
[96366] Infusion into a vein for therapy, prevention, or diagnosis (1)
[96377] Application of on-body injector for injection under skin (1)
[96401] Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle (3)
[96402] Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle (1)
[96405] Chemotherapy into a lesion, up to and including 7 lesions (2)
[96406] Chemotherapy into a lesion, more than 7 lesions (1)
[96409] Infusion of chemotherapy into a vein using push technique (2)
[99202] New patient outpatient visit, total time 15-29 minutes (1)
[99203] New patient outpatient visit, total time 30-44 minutes (1)
[99204] New patient outpatient visit, total time 45-59 minutes (1)
[99205] New patient outpatient visit, total time 60-74 minutes (1)
[99212] Established patient outpatient visit, total time 10-19 minutes (1)
[99213] Established patient outpatient visit, total time 20-29 minutes (1)
[99214] Established patient outpatient visit, total time 30-39 minutes (1)
[99215] Established patient outpatient visit, total time 40-54 minutes (1)

Showing 61 - 71 of 71 results

Previous| 1... 4 | 5 | 6 |Next

Simmons Cancer Center’s Dr. John Sweetenham to Chair National Comprehensive Cancer Network Board of Directors

Simmons Cancer Center’s Dr. John Sweetenham to Chair National Comprehensive Cancer Network Board of Directors

John Sweetenham, M.D., Associate Director for Clinical Affairs at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, has been elected Chair of the Board of Directors of the National Comprehensive Cancer Network (NCCN).

Grant Supports UTSW Push to Make Genomic Data More Accessible

Grant Supports UTSW Push to Make Genomic Data More Accessible

Researchers at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center are developing an innovative interface to make the wealth of genomics data from next-generation sequencing visible and actionable in real time for clinicians and researchers.

DARTBOARD: Novel head & neck cancer trial targets personalized, daily radiation therapy

DARTBOARD: Novel head & neck cancer trial targets personalized, daily radiation therapy

The DARTBOARD clinical trial will study daily adaptive radiotherapy on head and neck cancers using tumor targeting driven by an AI-driven algorithm developed by UT Southwestern.

Working to Reduce Cancer Disparities Across Our Community

Working to Reduce Cancer Disparities Across Our Community

The Office of Community Outreach, Engagement, and Equity is committed to maximizing the impact of Simmons research through community engagement in the DFW Metroplex and beyond.

Pioneering Initiatives to Modernize Cancer Care

Pioneering Initiatives to Modernize Cancer Care

New developments aim to improve clinical outcomes for cancer patients.

UT Southwestern Develops Nanotherapeutic to Ward Off Liver Cancer

UT Southwestern Develops Nanotherapeutic to Ward Off Liver Cancer

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver in mice.

Clinical Trial Shows Stereotactic Radiation Extends Systemic Therapy and Slows Kidney Cancer Progression

Clinical Trial Shows Stereotactic Radiation Extends Systemic Therapy and Slows Kidney Cancer Progression

A new study by the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center shows that highly focused radiation to isolated metastases that progress despite drug therapy can prolong drug efficacy in kidney cancer patients, saving the few other drugs for treating kidney cancer for future use.

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

UT Southwestern is leading research to find ways to extend the benefits of PARP-1 inhibitor maintenance medication to more patients with more forms of ovarian cancer.

Artificial Intelligence Algorithm Developed to Assess Metastatic Potential in Skin Cancers

Artificial Intelligence Algorithm Developed to Assess Metastatic Potential in Skin Cancers

Using artificial intelligence (AI), researchers from UT Southwestern have developed a way to accurately predict which skin cancers are highly metastatic.

The Consequences of Understaging Gastric Cancer

The Consequences of Understaging Gastric Cancer

Patients with nonspecific symptoms that overlap with the symptoms of gastric cancers should be evaluated at a center with extensive experience in treating these cancers.

Novel Biomarker Might Lead to Personalized, Targeted Therapy

Novel Biomarker Might Lead to Personalized, Targeted Therapy

ADP-ribosylation could help scientists predict PARP inhibitor sensitivity in ovarian and breast cancer patients.

Showing 61 - 71 of 71 results

Previous| 1... 4 | 5 | 6 |Next

Powered by BROADCASTMED

About UT Southwestern Medical Center

UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 25 members of the National Academy of Sciences, 19 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,900 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in more than 80 specialties to more than 100,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 4 million outpatient visits a year.